Latest filing published 22 Sept 2021 for GlaxoSmithKline plc, €49k.
Insider track record
No signal scores available.
Charles Bancroft: trading record in brief
All filings by Charles Bancroft on record concern GlaxoSmithKline plc. Over a trading history stretching from 29 July 2020 to 20 September 2021, the count stands at 6 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Most recently, on 22 September 2021, the filings show a share grant worth €49k in GlaxoSmithKline plc. Typically, a trade is published a median of 1 day after it takes place. For comparison, UK MAR gives managers three business days to notify a trade. Every figure here comes from the filings published by RNS (LSE) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Charles Bancroft
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,479.486 shares@ US$39.09N/AISIN US37733W1053FCA-NSM:4118924-1
- 1,469.711 shares@ US$39.35N/AISIN US37733W1053FCA-NSM:4078201-1
- 977.484 shares@ US$37.75N/AISIN US37733W1053FCA-NSM:3958103-1
- 817.943 shares@ US$37.39N/AISIN US37733W1053FCA-NSM:3868580-1
- 866.616 shares@ US$35.29N/AISIN US37733W1053FCA-NSM:3762711-1
- 500.844 shares@ US$40.82100.0% of flowN/AISIN US37733W1053FCA-NSM:3671412-1
6 of 6 declarations